Many biological targets including membrane receptors, cellular proteins and enzymes are large complex macromolecules on the scale of 1–100 nm. These macromolecules very often rely on multivalent interactions for binding and initiating biological processes. Yet, most pharmaceutical development thus far has focused on small molecular weight drugs that lack the capacity to interact with such targets in a multivalent manner.
Based on your knowledge of polymers, discuss, with the aid of your own diagrams/drawings, the type of polymer system that can be designed and developed to tackle this gap in pharmaceutical development.
